- ISPE Singapore Conference & Exhibition 2018: From Manufacturing to Patients
- Huami launches Health Band 1S and Smart Wearable AI Chip
- CISCRP releases a video to improve diversity in clinical research
- NUS team invents new diagnostic device
- Agendia and Genecast Biotech enter into a partnership
- General Atlantic invests $150M in Asia Medical
- Aurobindo Pharma gets SA health authority nod for HIV drug
- OUE Lippo to acquire stakes in first REIT and Bowsprit Capital
- Mascots, Lucence partner to deliver cancer blood tests in Myanmar
- SP, Shimadzu to prepare for digitalisation by 2020
- Neurimmune achieves milestone with Ono Pharmaceutical
- New AI tool accurately identifies lung cancer type
- BeiGene picks GE’s facility to boost cancer drugs production capacity
- BioCity wins contract to provide support to Scottish companies
-
Pharma | 05 January 2018 | News
AstraZeneca collaborates with Myriad Genetics for cancer therapy
AstraZeneca is working in collaboration with the molecular diagnostics firm Myriad Genetics’ for its tes...Read more
Digital Health | 05 January 2018 | News
Microsoft partners with Adaptive Biotechnologies
The tech giant Microsoft is partnering with Seattle biotech company Adaptive Biotechnologies on a year-long pr...Read more
-
Singapore | 19 September 2018 | News
ISPE Singapore Conference & Exhibition 2018: From Manufacturing to Patients
Singapore - The ISPE Singapore Conference & Exhibition 2018 closed to resounding success on 31st August at...Read more
-
World | 18 September 2018 | News
BioCity wins contract to provide support to Scottish companies
Life sciences incubator, BioCity, has won a contract tendered by Scottish Enterprise to provide specialist sup...Read more
-
Singapore | 18 September 2018 | News
SP, Shimadzu to prepare for digitalisation by 2020
Singapore – To better prepare laboratory analysts and technicians for future roles in a digitalised...Read more
-
Pharma | 04 January 2018 | News
Europe's biggest private biotech company raises $270 million
Europe’s largest privately held biotech company, Germany-based BioNTech, has raised $270 million to supp...Read more
Stem Cells: Framing the future of healthcare
Stem cells are believed to have the ability to divide without limit and to give rise to specialized cells. Stem cell research is an exciting yet complex and controversial science. It holds the promise of helping us better understand the most fundamental processes of cellular specialization and human development, and many nations have therefore invested heavily in stem cell research and its applications. Stem cell research is one of the most exciting areas of the 21st century science and has the potential to revolutionize the way we treat conditions, including regenerative diseases for which few effective treatments currently exist. There is a lot of hope invested in this field by researchers, governments and the general public.
